Levetiracetam Viatris (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a key role in regulating neurotransmitter release. This binding modulates calcium‑dependent exocytosis, stabilizing neuronal firing and reducing the hyper‑excitability that leads to seizure activity.

The prescribed dose of levetiracetam is individualized by the treating physician based on the patient’s age, weight, renal function, and seizure type. The prescriber determines the starting dose and any subsequent titration to achieve optimal seizure control while minimizing side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or phenytoin, levetiracetam has a distinct mechanism (SV2A binding) and a relatively favorable drug‑interaction profile. It is often chosen for patients who need a medication with fewer enzyme‑inducing effects, though individual response and tolerability vary.

Levetiracetam tablets should be stored at temperatures below 25 °C, in their original container, protected from moisture and direct sunlight. Keeping the product in a dry, controlled environment helps maintain its potency throughout its shelf life.

Levetiracetam Viatris is taken orally, with or without food, as directed by the prescriber. Tablets should be swallowed whole with water; they are not intended for crushing, chewing, or splitting unless specifically advised by a healthcare professional.

Serious adverse events, although rare, include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes like depression or suicidal thoughts, and blood disorders such as neutropenia or thrombocytopenia. Patients should seek immediate medical attention if they notice any of these symptoms.

Levetiracetam is contraindicated in individuals with a known hypersensitivity to the drug or any of its excipients. Patients with severe renal impairment should avoid use unless a dose adjustment is made under medical supervision. Caution is also advised for those with a history of mood disorders.